Wide Ranks

INCR

Intercure Ltd.

1.35

Top Statistics
Market Cap 61 M Forward PE -0.9122 Revenue Growth -38.60 %
Current Ratio 1.77 Trailing PE 0.0000 Earnings Growth -84.70 %
Profit Margins -24.07 % Peg Ratio Dividend Yield 0.00 %
Enterprice / EBITA 66.62 Enterprise / Revenue 0.7210 Price To Sales Trailing12 Months 0.2266
Profitability
Profit Margins -24.07 % Operating Margins 8.20 %
Balance Sheet
Total Cash 20 M Total Cash Per Share 0.4250 Total Debt 150 M
Total Debt To Equity 32.63 Current Ratio 1.77 Book Value Per Share 9.64
All Measures
Short Ratio 39.00 % Message Board Id finmb_36626000 Fax 972 9 768 0244
Shares Short Prior Month 17825 Return On Equity -0.1361 City Herzliya
Uuid fc67535e-5273-3466-beba-3c06c0dbd988 Previous Close 1.45 First Trade Date Epoch Utc 1 B
Book Value 9.64 Beta 0.0330 Total Debt 150 M
Volume 56480 Price To Book 0.1401 Fifty Two Week Low 1.17
Total Cash Per Share 0.4250 Total Revenue 272 M Shares Short Previous Month Date 1 B
Max Age 86400 Sand P52 Week Change 0.3133 Operating Margins 8.20 %
Net Income To Common -65623000 Short Percent Of Float 0.0006 Implied Shares Outstanding 48 M
Trailing Peg Ratio None Last Fiscal Year End 1 B Average Daily Volume10 Day 62720
Average Volume10days 62720 Total Cash 20 M Next Fiscal Year End 1 B
Revenue Per Share 5.89 Held Percent Insiders 0.3960 Ebitda Margins 1.08 %
Trailing PE 0.0000 Date Short Interest 1 B Most Recent Quarter 1 B
Regular Market Previous Close 1.45 Target Low Price 0.0000 Gmt Off Set Milliseconds -18000000
Fifty Day Average 1.67 Open 1.36 Dividend Yield 0.00 %
Return On Assets -0.0024 Time Zone Short Name EST Trailing Eps -0.4000
Day Low 1.34 Address1 85 Medinat ha-Yehudim Street Shares Outstanding 45 M
Price Hint 4 Target High Price 0.0000 Website https://www.intercure.co
52 Week Change 0.0976 Average Volume 32310 Earnings Quarterly Growth -85.30 %
Forward Eps -1.48 Recommendation Key none Compensation As Of Epoch Date 1 B
Quick Ratio 114.90 % Is_sp_500 False Regular Market Day High 1.40
Profit Margins -24.07 % Debt To Equity 32.63 Fifty Two Week High 3.72
Day High 1.40 Shares Short 16229 Regular Market Open 1.36
Industry Key drug-manufacturers-specialty-generic Earnings Growth -84.70 % Enterprise To Revenue 0.7210
Revenue Growth -38.60 % Shares Percent Shares Out 0.0004 Currency USD
Time Zone Full Name America/New_York Market Cap 61 M Is_nasdaq_100 False
Zip 4676670 Quote Type EQUITY Industry Drug Manufacturers - Specialty & Generic
Long Name InterCure Ltd. Regular Market Day Low 1.34 Held Percent Institutions 0.1161
Current Price 1.35 Enterprise To Ebitda 66.62 Financial Currency ILS
Current Ratio 1.77 Gross Margins 28.60 % Industry Disp Drug Manufacturers - Specialty & Generic
Country Israel Float Shares 26 M Two Hundred Day Average 2.18
Ir Website http://www.resperate.com/investor-relations/ Enterprise Value 196 M Price To Sales Trailing12 Months 0.2266
Forward PE -0.9122 Regular Market Volume 56480 Ebitda 2 M
Exchange NGM
Go to Yahoo Finance Go to Seeking Alpha 
InterCure Ltd.

, together with its subsidiaries, engages in the research, cultivation, production, and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use in Israel and internationally.

The company offers dried cannabis inflorescences and cannabis extract mixed with oil.

It also invests in the biomed sector.

The company was incorporated in 1994 and is headquartered in Herzliya, Israel.